CAR T cells are autologous T cells engineered to express a transmembrane CAR specific for a defined tumour antigen that signals via canonical TCR signalling intermediates such as LCK (Yong et al, 2017; Davenport et al, 2018). Here, LCK is linked to neoplasm.